The aging hypertensive kidney: pathophysiology and therapeutic options

Area of Science:

• Nephrology
• Gerontology
• Cardiovascular Medicine

Background:

• Kidney aging involves hemodynamic changes like reduced glomerular filtration rate and renal plasma flow.
• These changes, linked to vascular alterations and renal mass loss, increase susceptibility to kidney diseases.
• Hypertensive nephrosclerosis is a major cause of end-stage renal disease, particularly in older adults.

Purpose of the Study:

• To explore the relationship between aging, hypertension, and kidney disease.
• To investigate the role of angiotensin II in progressive renal impairment.
• To identify potential therapeutic strategies for renal protection in hypertensive individuals.

Main Methods:

• Review of hemodynamic and structural changes in aging and hypertensive kidneys.
• Analysis of the role of angiotensin II in intrarenal microcirculation.
• Discussion of drug classes with potential renal protective effects.

Main Results:

• Aging kidneys show reduced filtration and blood flow, increasing disease risk.
• Hypertensive nephrosclerosis accentuates age-related kidney changes.
• Excessive angiotensin II production may drive progressive renal impairment.

Conclusions:

• Renal protection requires normalizing systemic and glomerular capillary pressures.
• Attenuating intrarenal angiotensin II effects is crucial for kidney health.
• Angiotensin-converting enzyme inhibitors and calcium antagonists show promise, but long-term trials are needed.